Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)

CUSIP: 45254E107

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Class A common stock, par value $0.001 per share
Shares outstanding
66,027,379
Total 13F shares
26,061,962
Share change
+21,708,848
Total reported value
$182,434,908
Price per share
$7.00
Number of holders
69
Value change
+$152,080,293
Number of buys
55
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 45254E107?
CUSIP 45254E107 identifies IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q3 2025

As of 30 Sep 2025, Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,061,962 shares. The largest 10 holders included FMR LLC, Sanofi, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, ExodusPoint Capital Management, LP, Logos Global Management LP, CITADEL ADVISORS LLC, BlackRock, Inc., Blue Owl Capital Holdings LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.